CLRB
Cellectar Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website cellectar.com
- Employees(FY) 15
- ISIN US15117F8077
Performance
+1.85%
1W
-0.3%
1M
-4.21%
3M
+65.0%
6M
+19.13%
YTD
+127.59%
1Y
Profile
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r pediatric patients with head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Technical Analysis of CLRB 2024-05-10
Overview:
In analyzing the technical indicators for CLRB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-14 20:18
- 2024-05-14 15:43
Q1 2024 Cellectar Biosciences Inc Earnings Call(Yahoo Finance)
- 2024-05-14 15:02
- 2024-05-13 22:53
- 2024-05-13 18:40
- 2024-05-07 18:40
- 2024-05-06 18:40
- 2024-03-27 22:33
- 2024-03-27 10:09
Q4 2023 Cellectar Biosciences Inc Earnings Call(Yahoo Finance)
- 2024-03-26 22:53
- 2024-03-26 18:40
- 2024-03-19 18:40
- 2024-03-13 20:52
- 2024-03-03 17:40
- 2024-02-06 17:40
- 2024-01-29 17:40
- 2024-01-24 17:40
- 2024-01-21 17:40
- 2024-01-15 17:40
- 2024-01-11 17:44
- 2024-01-10 17:40
- 2024-01-07 19:37
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?(Investorplace)
- 2024-01-07 17:40
Cellectar's blood cancer therapy succeeds in trial(Yahoo Finance)
- 2024-01-07 17:30
- 2024-01-02 19:30
- 2023-12-18 19:30
- 2023-12-11 19:30
- 2023-12-04 19:30
- 2023-11-04 00:36
- 2023-11-01 19:30
Page 1 of 4
previousnext